Abstract
We investigated the inhibition of trypsin, human tissue (hK1) and human plasma kallikrein (HuPK), papain, and cathepsin L, B, and X by synthetic cyclic, cycloretro-isomer, cycloretroinverso, and linear peptides derived from the C-terminal sequence of bradykinin. c(FSPFRG) and Ac-FSPFRG-NH2 were taken as the references for cyclic and linear peptides, respectively. Longer and more flexible analogs of them with addition of 2, 3, or 4 Gly and cycloretro-isomer and cycloretro-inverso analogs of c(FSPFRG) and c(GGGFSPFRG) were obtained and assayed. The susceptibility to hydrolysis of the peptides to all proteases was also examined. The highest affinities were found for c(FSPFRG) with hK1, Ac-GGFSPFRG-NH2 with HuPK, and ψ(NHCO) c(fspfrG) with cathepsin L. The Ki values for cathepsin B and X with cyclic peptides were lower than those of linear peptides. The serine proteases hydrolyzed all linear and cyclic peptides, except c(FSPFRG) and c(GFSPFRG). The cysteine proteases hydrolyzed only the linear peptides, which were poor substrates. Although the Ki values obtained in the current work were in the μM range, the cyclic and cycloretro-inverso peptides seem to be a promising approach to develop efficient and resistant to hydrolysis inhibitors for the kallikreins and lysosomal cysteine proteases.
Similar content being viewed by others
References
Alves, L. C., Almeida, P. C., Franzoni, L., Juliano, L., and Juliano, M. A. (1996). J. Pept. Res. 9: 92-96.
Alves, L. C., Judice, W. A., St Hilaire, P. M., Meldal, M., Sanderson, S. J., Mottram, J. C., et al. (2001). Mol. Biochem. Parasitol. 116: 1-9.
Alves, M. F., Puzer, L., Cotrin, S. S., Juliano, M. A., Juliano, L., Bromme, D., et al. (2003). Biochem. J. 373: 981-986.
Apostoluk, W., and Otlewski, J. (1998). Proteins: Structure, Function and Genetics 32: 459-474.
Barlos, K., Gatos, D., Kutsogianni, S., Papaphotiou, G., Poulos, C., and Tsegenidis, T. (1991). Int. J. Pept. Protein Res. 38: 562-568.
Barrett, A. J., and Kirshke, H. (1981). Methods Enzymol. 80: 771-778.
Carmona, E., Dufour, E., Plouffe, C., Takebe, S., Mason, P., Mort, J. S., et al. (1996). Biochemistry 35: 8149-8157.
Chase, J. T., and Shaw, E. (1970). Methods Enzymol. 19: 20-22.
Cygler, M., and Mort, J. S. (1997). Biochimie 79: 645-652.
Dias, C. L. F., and Rogana, E. (1986). Braz. J. Med. Biol. Res. 19: 11-18.
Emim, J. A., Souccar, C., Castro, M. S., Godinho, R. O., Cezari, M. H., Juliano, L., et al. (2000). Br. J. Pharmacol. 130: 1099-1107.
Fairlie, D. P., Tyndall, J. D., Reid, R. C., Wong, A. K., Abbenante, G., Scanlon, M. J., et al. (2000). J. Med. Chem. 43: 1271-1281.
Fletcher, M. D., and Campbell, M. M. (1998). Chem. Rev. 98: 763-796.
Guay, J., Falgueyret, J. P., Ducret, A., Percival, M. D., and Mancini, J. A. (2000). Eur. J. Biochem. 267: 6311-6318.
Guncar, G., Klemencic, I., Turk, B., Turk, V., Karaoglanovic-Carmona, A., Juliano, L., et al. (2000). Structure Fold Des. 8: 305-313.
Klemencic, I., Carmona, A. K., Cezari, M. H., Juliano, M. A., Juliano, L., Guncar, G., et al. (2000). Eur. J. Biochem. 267: 5404-5412.
Laskowski, M., Jr., and Kato, I. (1980). Annu. Rev. Biochem. 49: 593-626.
Lecaille, F., Kaleta, J., and Bromme, D. (2002). Chem. Rev. 102: 4459-4488.
Leung, D., Abbenante, G., and Fairlie, D. P. (2000). J. Med. Chem. 43: 305-341.
Marx, U. C., Korsinczky, M. L., Schirra, H. J., Jones, A., Condie, B., Otvos, L., Jr., et al. (2003). J. Biol. Chem. 278: 21782-21789.
McBride, J. D., Freeman, N., Domingo, G. J., and Leatherbarrow, R. J. (1996). J. Mol. Biol. 259: 819-827.
McBride, J. D., Watson, E. M., Brauer, A. B., Jaulent, A. M., and Leatherbarrow, R. J. (2002). Biopolymers 66: 79-92.
Melo, R. L., Alves, L. C., Del Nery, E., Juliano, L., and Juliano, M. A. (2001). Anal. Biochem. 293: 71-77.
Ménard, R., Khouri, H. E., Plouffe, C., Dupras, R., Rippoli, D., Vernet, T. Tessier, D. C., et al. (1990). Biochemistry 29: 6706-6713.
Nägler, D. K., Storer, A. C., Portaro, F. C. V., Carmona, E., Juliano, L., and Ménard, R. (1997). Biochemistry 36: 12608-12615.
Nägler, D. K., Tam, W., Storer, A. C., Krupa, J. C., Mort, J. S., and Menard, R. (1999a). Biochemistry 38: 4868-4874.
Nägler, D. K., Zhang, R., Tam, W., Sulea, T., Purisima, E. O., and Ménard, R. (1999b). Biochemistry 38: 12648-12654.
Nicklin, M. J., and Barrett, A. J. (1984). Biochem. J. 223: 245-253.
Oliva, M. L., Grisolia, D., Sampaio, M. U., and Sampaio, C. A. M. (1982). Agents and Actions Suppl. 9: 52-57.
Otlewski, J., Krowarsch, D., and Apostoluk, W. (1999). Acta Biochim. Pol. 46: 531-565.
Portaro, F. C., Santos, A. B., Cezari, M. H., Juliano, M. A., Juliano, L., and Carmona, E. (2000). Biochem. J. 347: 123-129.
Radisky, E. S., and Koshland, D. E., Jr. (2002). Proc. Natl. Acad Sci. U. S. A. 99: 10316-10321.
Rowan, A. D., Mason, P., Mach, L., and Mort, J. S. (1992). J. Biol. Chem. 267: 15993-15999.
Sampaio, C. A. M., Sampaio, M. U., and Prado, E. S. (1984). Hoppe Seyler's Z. Physiol. Chem. 365: 297-302.
Sampson, M. T., and Kakkar, A. K. (2002). Biochem. Soc. Trans. 30: 201-207.
Schechter, I., and Berger, A. (1967). Biochem. Biophys. Res. Comm. 27: 157-162.
Shimamoto, K., Chao, J., and Margolius, H. S. (1980). J. Endocrinol. Metab. 51: 840-848.
St Hilaire, P. M., Alves, L. C., Herrera, F., Renil, M., Sanderson, S. J., Mottram, J. C., et al. (2002). J. Med.Chem. 45: 1971-1982.
Tyndall, J. D., and Fairlie, D. P. (2001). Curr. Med. Chem. 8: 893-907.
Yan, S., Sameni, M., and Sloane, B. F. (1998). Biol. Chem. 379: 113-123.
Yousef, G. M., and Diamandis, E. P. (2003). Thromb. Haemost. 90: 7-16.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lima, A.R., Juliano, L. & Juliano, M.A. Cyclic, Linear, Cycloretro-Isomer, and Cycloretro-Inverso Peptides Derived from the C-Terminal Sequence of Bradykinin as Substrates or Inhibitors of Serine and Cysteine Proteases. J Protein Chem 23, 287–294 (2004). https://doi.org/10.1023/B:JOPC.0000027853.93513.34
Issue Date:
DOI: https://doi.org/10.1023/B:JOPC.0000027853.93513.34